| Active substance | Pritelivir |
| Holder | myTomorrows |
| Status | Running |
| Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
| Public documents | |
| Last update | 29/082025 |
| Active substance | Pritelivir |
| Holder | myTomorrows |
| Status | Running |
| Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
| Public documents | |
| Last update | 29/082025 |